KFSHRC Inks Agreement with Rady Institute for Genetic Screening of Newborns
The agreement was signed at KFSHRC’s Riyadh headquarters, with Dr. Björn Zoëga, CEO of KFSHRC in Riyadh, and Professor Stephen Kingsmore, President and CEO of the Rady Children’s Institute, representing their institutions, in the presence of senior leaders from both sides.
The collaboration covers key areas: collecting and analyzing genomic sequencing data for newborns, conducting joint clinical research to assess the benefits and cost-effectiveness of genetic screening, developing globally applicable protocols, and raising community awareness while training healthcare professionals in genetic testing.
This agreement represents a strategic step that strengthens KFSHRC’s role in precision medicine and genetic testing, while opening avenues for collaboration with leading international research institutions to advance medical practice and scientific innovation.
KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world’s top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. It was included in the world's best 250 hospitals and in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.
Riyadh
King Faisal Specialist Hospital and Research Centre
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
